BUFFALO, N.Y. (AP) _ Athenex Inc. (ATNX) on Wednesday reported a loss of $46.2 million in its third quarter.
The Buffalo, New York-based company said it had a loss of 70 cents per share. Losses, adjusted for non-recurring costs, came to 33 cents per share.
The biopharmaceutical company posted revenue of $18.4 million in the period.
Athenex expects full-year revenue in the range of $100 million to $125 million.
Athenex shares have fallen 27 percent since the beginning of the year. The stock has decreased 30 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNX at https://www.zacks.com/ap/ATNX